COMP <GO>
PDC vs SLE // EV/EBITDA & P/E VALUATION
Perpetuals.com Ltd (NASDAQ) VS. Super League Enterprise Inc. (NASDAQ) • 15-METRIC TALLY: PDC 3
— SLE 1
■ METRIC PARITY
LAST: $2.33 (-20.20%) • MKT CAP: $18.9M
valuation
—
LAST: $4.75 (-5.38%) • MKT CAP: $15.5M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PDC VS. SLE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PDC | SLE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 59.50% | 40.50% | +19.00 | PDC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -21.66% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -47.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 3/9 | -1.00 | SLE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.5 | 42.9 | +1.57 | PDC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $18.9M | $15.5M | $3.4M | PDC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PDC REV | SLE REV | PDC GROSS % | SLE GROSS % | PDC FCF | SLE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.6M | $11.3M | 59.5% | 40.5% | -$4.1M | -$10.7M |
| FY 2024 | $3.1M | $16.2M | 51.6% | 37.7% | -$1.3M | -$11.5M |
| FY 2023 | $1.1M | $0 | — | — | -$2.5M | -$15.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PDC // BETA —
SLE // BETA —